Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cardio Diagnostics Holdings (CDIO) Enterprise Value (2021 - 2025)

Cardio Diagnostics Holdings' Enterprise Value history spans 5 years, with the latest figure at -$8.0 million for Q2 2025.

  • For Q2 2025, Enterprise Value fell 508.07% year-over-year to -$8.0 million; the TTM value through Jun 2025 reached -$8.0 million, down 508.07%, while the annual FY2024 figure was -$7.8 million, 509.84% down from the prior year.
  • Enterprise Value for Q2 2025 was -$8.0 million at Cardio Diagnostics Holdings, down from -$7.8 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$9681.0 in Q3 2021 and bottomed at -$74.7 million in Q2 2022.
  • The 5-year median for Enterprise Value is -$4.6 million (2022), against an average of -$20.1 million.
  • The largest annual shift saw Enterprise Value plummeted 769834.83% in 2022 before it surged 95.13% in 2023.
  • A 5-year view of Enterprise Value shows it stood at -$65.5 million in 2021, then surged by 93.71% to -$4.1 million in 2022, then surged by 68.83% to -$1.3 million in 2023, then crashed by 509.84% to -$7.8 million in 2024, then dropped by 1.78% to -$8.0 million in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Enterprise Value are -$8.0 million (Q2 2025), -$7.8 million (Q4 2024), and -$2.0 million (Q3 2024).